Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07088211
What this trial is testing

Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 39
Testing effectiveness (Phase 2)UnknownNCT05522894
What this trial is testing

AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

Who this might be right for
Unresectable Esophageal Squamous Cell CarcinomaLocally Advanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
Chinese Academy of Medical Sciences 80
Testing effectiveness (Phase 2)Study completedNCT00096031
What this trial is testing

S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06331845
What this trial is testing

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Metastatic Nasopharyngeal CarcinomaIntermittent Systematic Chemotherapy
Fujian Cancer Hospital 39
Testing effectiveness (Phase 2)Study completedNCT04220866
What this trial is testing

Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Merck Sharp & Dohme LLC 18
Testing effectiveness (Phase 2)UnknownNCT00363831
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
The University of Hong Kong 42
Testing effectiveness (Phase 2)UnknownNCT05136768
What this trial is testing

Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC)

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastasesImmunotherapy+1 more
Jun-Lin Yi, MD 50
Testing effectiveness (Phase 2)UnknownNCT06063018
What this trial is testing

RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer Recurrent
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00189410
What this trial is testing

Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours

Who this might be right for
Cancer of the Ovary Treated as 2nd Line TherapyMuellerian Mixed TumoursTumours of the Uterus+2 more
AGO Study Group 140
Testing effectiveness (Phase 2)Study completedNCT01289522
What this trial is testing

Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Head and Neck CarcinomaRecurrent or Metastatic Disease
Groupe Oncologie Radiotherapie Tete et Cou 54
Testing effectiveness (Phase 2)Study completedNCT01040832
What this trial is testing

EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck Cancer
EMD Serono 107
Large-scale testing (Phase 3)Looking for participantsNCT04415853
What this trial is testing

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

Who this might be right for
Esophageal Cancer
Sunshine Lake Pharma Co., Ltd. 416
Testing effectiveness (Phase 2)Active Not RecruitingNCT01142388
What this trial is testing

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Metastatic Esophageal AdenocarcinomaMetastatic Esophageal Squamous Cell CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+5 more
National Cancer Institute (NCI) 94
Not applicableLooking for participantsNCT07448727
What this trial is testing

Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT

Who this might be right for
Head & Neck CancerHead & Neck Squamous Cell Carcinoma
University of Rome Tor Vergata 25
Testing effectiveness (Phase 2)UnknownNCT01336049
What this trial is testing

Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Cancer
Peking University 70
Testing effectiveness (Phase 2)UnknownNCT03126708
What this trial is testing

Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer, Squamous CellCetuximab EffectChemotherapy Effect
Peking University 150
Not applicableStudy completedNCT01952821
What this trial is testing

Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Mayo Clinic 66
Large-scale testing (Phase 3)Study completedNCT03635567
What this trial is testing

Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 617
Testing effectiveness (Phase 2)Study completedNCT00865098
What this trial is testing

Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Who this might be right for
Carcinoma of the Head and Neck
Merck KGaA, Darmstadt, Germany 27
Testing effectiveness (Phase 2)UnknownNCT06464614
What this trial is testing

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Henan University of Science and Technology 54
Next Page